Traditionally, pro-inflammatory cytokines, such as IL-6 and TNF-α as well as IL-1β and matrix metalloproteinases (MMPs), have been studied in a wide range of medical conditions including ischemic and hemorrhagic stroke as a surrogate for predicting poor outcomes [42–44]. This evidence concerns the gene IL6 and hemorrhagic stroke.